STELTRIS Trademark

Trademark Overview


On Thursday, January 8, 2015, a trademark application was filed for STELTRIS with the United States Patent and Trademark Office. The USPTO has given the STELTRIS trademark a serial number of 86498159. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, June 3, 2016. This trademark is owned by Glaxo Group Limited. The STELTRIS trademark is filed in the Pharmaceutical Products category with the following description:

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the tre...
steltris

General Information


Serial Number86498159
Word MarkSTELTRIS
Filing DateThursday, January 8, 2015
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, June 3, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Services(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 20, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, June 3, 2016ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, June 3, 2016ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, June 3, 2016ASSIGNED TO EXAMINER
Monday, November 2, 2015NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, November 2, 2015INQUIRY TO SUSPENSION E-MAILED
Monday, November 2, 2015SUSPENSION INQUIRY WRITTEN
Monday, October 19, 2015LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, October 7, 2015ASSIGNED TO LIE
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 24, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, March 24, 2015LETTER OF SUSPENSION E-MAILED
Tuesday, March 24, 2015SUSPENSION LETTER WRITTEN
Tuesday, March 24, 2015ASSIGNED TO EXAMINER
Tuesday, January 20, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 12, 2015NEW APPLICATION ENTERED IN TRAM